Glioblastoma Achilles heel spotted, hints at stronger therapies
TL;DR Summary
In preclinical models, blocking the SET protein reactivates the tumor-suppressing enzyme PP2A, reducing glioblastoma growth and making cancer cells more sensitive to radiation, offering a potential way to enhance standard therapies; human trials are needed to assess safety and efficacy.
- Scientists find a weak spot in one of the deadliest brain cancers Science Daily
- UVA researchers identify possible new target for treating deadly brain cancer WVIR
- Lethal Brain Cancer: Breakthrough as SET EIP Is Targeted to Prevent Glioblastoma Tumours Dawan Africa
- Targeting Calcium Could Improve Outcomes for Deadly Brain Cancer, Discovery Suggests uvahealth.com
Reading Insights
Total Reads
1
Unique Readers
4
Time Saved
5 min
vs 6 min read
Condensed
96%
1,066 → 40 words
Want the full story? Read the original article
Read on Science Daily